Abstract
The mainstay treatment for metastatic prostate cancer disease aims to reduce systemic testosterone levels, which can be achieved surgically or by chemical castration, known as androgen deprivation therapy (ADT).
Original language | English |
---|---|
Pages | 17-17 |
Number of pages | 1 |
Publication status | Published - 2018 |
Event | 19th Asia-Pacific Prostate Cancer Conference - Brisbane Convention Centre, Brisbane, Australia Duration: 22 Aug 2018 → 25 Aug 2018 |
Conference
Conference | 19th Asia-Pacific Prostate Cancer Conference |
---|---|
Abbreviated title | APPC 2018 |
Country/Territory | Australia |
City | Brisbane |
Period | 22/08/18 → 25/08/18 |